Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126442531 | 12644253 | 1 | I | 20160809 | 20160811 | 20160811 | EXP | AU-009507513-1608AUS005984 | MERCK | 0.00 | M | Y | 0.00000 | 20160811 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126442531 | 12644253 | 1 | PS | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | UNK | U | 20829 | TABLET | |||||||||
| 126442531 | 12644253 | 2 | SS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | UNK | U | 0 | ||||||||||
| 126442531 | 12644253 | 3 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126442531 | 12644253 | 1 | Graft versus host disease in lung |
| 126442531 | 12644253 | 2 | Graft versus host disease in lung |
| 126442531 | 12644253 | 3 | Graft versus host disease in lung |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126442531 | 12644253 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126442531 | 12644253 | Disease recurrence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |